Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event

Molecular and Cellular Biology

Volumn 21, Issue 13, 2001, Pages 4149-4161

  Leight, E R ^a   Sugden, B ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYGROMYCIN; PHOSPHOTRANSFERASE; VIRUS PROTEIN;

ARTICLE; CELL CLONING; CELL CYCLE; CONTROLLED STUDY; DNA SYNTHESIS; EPSTEIN BARR VIRUS; ESCHERICHIA COLI; HUMAN; HUMAN CELL; PLASMID; PRIORITY JOURNAL; REPLICON; VIRUS REPLICATION;

CELL LINE; DNA REPLICATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENES, REPORTER; HERPESVIRUS 4, HUMAN; HUMANS; PLASMIDS; RECOMBINANT FUSION PROTEINS; REPLICATION ORIGIN; REPLICON; TIME FACTORS; TRANSFECTION; VIRUS REPLICATION;

ESCHERICHIA COLI; HUMAN HERPESVIRUS 4;

EID: 0034967536     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.13.4149-4161.2001     Document Type: Article

References (52)

1. Replication of latent Epstein-Barr virus genomes in Raji cells
2. Fusions between Epstein-Barr viral nuclear antigen-1 of Epstein-Barr virus and the large T-antigen of simian virus 40 replicate their cognate origins
3. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element
4. Sister chromatid separation and chromosome re-duplication are regulated by different mechanisms in response to spindle damage
5. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA
6. DNA replication checkpoint control
7. Checkpoints controlling mitosis
8. S-phase-promoting cyclin-dependent kinases prevent re-replication by inhibiting the transition of replication origins to a pre-replicative state
9. Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats
10. Regulation of mammalian replication origin usage in Xenopus egg extract
11. Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres
12. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication
13. Site-specific initiation of DNA replication in Xenopus egg extract requires nuclear structure
14. Histone deacetylase homologs regulate epigenetic inheritance of transcriptional silencing and chromosome segregation in fission yeast
15. Sequence requirements of the Epstein-Barr virus latent origin of DNA replication
16. Temporal order of S phase and mitosis in fission yeast is determined by the state of the p34cdc2-mitotic B cyclin complex
17. Selective extraction of polyoma DNA from infected mouse cell cultures
18. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells
19. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus
20. Plasmid maintenance of derivatives of oriP of Epstein-Barr virus
21. Rep*: A viral element that can partially replace the origin of plasmid DNA synthesis of Epstein-Barr virus
22. Electroporation: Parameters affecting transfer of DNA into mammalian cells
23. Genetic analysis of the mitotic transmission of minichromosomes
24. Isolation of human sequences that replicate autonomously in human cells
25. EBNA-1: A protein pivotal to latent infection by Epstein-Barr virus
26. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells
27. The linking regions of EBNA1 are essential for its support of replication and transcription
28. Mapping EBNA-1 domains involved in binding to metaphase chromosomes
29. Retention of plasmid DNA in mammalian cells is enhanced by binding of the Epstein-Barr virus replication protein EBNA1
30. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus
31. DNA polymerase epsilon links the DNA replication machinery to the S phase checkpoint
32. Activation of S-phase-promoting CDKs in late G1 defines a "point of no return" after which Cdc6 synthesis cannot promote DNA replication in yeast
33. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region
34. An EBNA-negative, EBV-genome-positive human lymphoblast cell line in which superinfecting EBV DNA is not maintained
35. A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components
36. Chromatin proteins involved in the initiation of DNA replication
37. Identification of minimal oriP of Epstein-Barr virus required for DNA
38. Requirement of replication licensing for the dyad symmetry element-dependent replication of the Epstein-Barr virus oriP minichromosome
39. EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance
40. Nucleosome positioning can affect the function of a cis-acting DNA element in vivo
41. A novel epigenetic effect can alter centromere function in fission yeast
42. Telomeric chromatin modulates replication timing near chromosome ends
43. DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: Stabilization of an origin complex with Epstein-Barr nuclear antigen 1
44. EBV's plasmid replicon: An enigma in cis and trans
45. A vector that replicates as a plasmid and can be efficiently selected in B-lymphoblasts transformed by Epstein-Barr virus
46. Plasmid origin of replication of Epstein-Barr virus, oriP, does not limit replication in cis
47. CD21-mediated entry and stable infection by Epstein-Barr virus in canine and rat cells
48. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells
49. The minimal replicator of Epstein-Barr virus oriP
50. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells
51. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells